Growth hormone secretagogues: discovery of small orally active molecules by peptidomimetic strategies.
Ankersen
Michael
M
Novo Nordisk A/S, Novo Nordisk Park, DK-2760 Denmark.
D000818:Animals; D015195:Drug Design; D013006:Growth Hormone / Q000172:deficiency / Q000378:metabolism*; D013007:Growth Hormone-Releasing Hormone / Q000737:chemistry / Q000494:pharmacology*; D006133:Growth Substances / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D018716:Molecular Mimicry; D009842:Oligopeptides / Q000737:chemistry / Q000494:pharmacology*; D013329:Structure-Activity Relationship
D006133:Growth Substances; D009842:Oligopeptides; D013006:Growth Hormone; D013007:Growth Hormone-Releasing Hormone